Cardiology Conference Reveals Limited Benefit from Vytorin use
by Neva J. Howell unless otherwise noted
Are you taking Vytorin for high cholesterol? It may not be helping as much as you hoped.
Findings stated that Vytorin (and Zetia, which is a component of Vytorin) demonstrated only limited proof of benefit in reducing high cholesterol. The article states:
“The study tested whether Vytorin was better than Zocor alone at limiting plaque buildup in the arteries of 720 people with super high cholesterol because of a gene disorder. The results show the drug had “no result — zilch. In no subgroup, in no segment, was there any added benefit” for reducing plaque, said Dr. John Kastelein, the Dutch scientist who led the study. That happened even though Vytorin dramatically lowered LDL, fats in the blood called triglycerides and a measure of artery inflammation — CRP.”
To read more on the cardiology report on Vytorin and Zetia, please check this article on
Vytorin and Zetia Failure